The initial euphoria over the GLP-1 drugs like Ozempic has mellowed, but catalysts expected in 2025 could energize investor interest in the stocks.
Related Posts
Vietnam has been a big beneficiary of global trade — Trump’s new tariffs threaten to derail that
Trump’s aggressive tariffs are threatening to derail Vietnam’s ambitious growth target as diplomatic overtures to Washington are unlikely to shift policy.
Trump rips into ‘too late’ Jerome Powell after Fed holds rates steady
President Donald Trump has long criticized Federal Reserve Chair Jerome Powell for not lowering interest rates.
Nvidia CEO says robotics is chipmaker’s biggest opportunity after AI
Nvidia CEO Jensen Huang said at the company’s annual shareholders meeting on Wednesday that robotics is a rapidly growing business.